Pivot Monetizes “RTIC” Technology And Enters Nevada Cannabis Market With Strategic Partner


Ryan Allway

August 8th, 2018

News, Top News


Transaction Includes Licensing, Manufacturing, Co-marketing and Distribution Agreements

VANCOUVER, Aug. 8, 2018 /PRNewswire/ – Pivot Pharmaceuticals Inc. (CSE: PVOT / OTCQB: PVOTF / FRA: NPAT) (“Pivot” or the “Company”) is pleased to announce that its wholly-owned subsidiary, Pivot Naturals LLC, has entered into a Binding Letter of Intent with Healthcare Options for Patients Enterprises LLC, dba HOPE Cannabis Products (“HOPE”). Based in Las Vegas, Nevada, HOPE is a fully licensed extractor, manufacturer and distributor of cannabis products including effect-based vape cartridges, syringes, micro-dosed oral sprays, pre-rolls, infused pre-rolls, infused cold brew coffee and infused lemonade.

Highlights:

  • Pivot enters Nevada cannabis market with a strategic partner;
  • HOPE is fully licensed to manufacture, distribute and sell cannabis products in Nevada;
  • Pivot to receive 10% royalty payment on Net Sales from all RTIC based-products sold by HOPE in Nevada;
  • HOPE to manufacture and distribute ‘Pivot Naturals’ product line in Nevada;
  • Pivot to manufacture and distribute HOPE’s product line in California;

Definitive Agreements will be completed on or before August 31, 2018 and will include the following:

(i)

Non-exclusive grant of license to HOPE to commercialize Pivot’s “RTIC” Ready-To-Infuse Cannabis powder technology, solely in Nevada;

(ii)

Co-Marketing and Distribution Agreements will allow Pivot and HOPE to sell each other’s products in Nevada and California;

(iii)

Manufacturing Agreement whereby Pivot shall manufacture HOPE’s products at Pivot’s facility in Costa Mesa, California (pending receipt of appropriate licenses);

(iv)

Manufacturing Agreement whereby HOPE shall manufacture Pivot’s products at HOPE’s licensed manufacturing facility in Las Vegas, Nevada.

HOPE was founded by a group of medical doctors who felt the time was right to harness the healing power of cannabis. They set out to create a company that would develop cannabis products to help people improve their lives. All of HOPE’s products are produced with the finest cannabis and use only the healthiest extraction methods to ensure their customers get the best and safest cannabis experience.

Dr. Howard Rubin, HOPE’s CEO, commented, “We are excited to work with the Pivot team and will immediately work to coordinate the production and sale of the RTIC powder so that we can provide Nevada consumers, as well as other licensed cannabis edible manufacturers, unique solutions and a suite of cannabis powderized products.”

Patrick J. Rolfes, President of Pivot Naturals LLC, stated, “I am thrilled that we have partnered with such an ethical and forward thinking company. This partnership not only monetizes the RTIC technology, but validates our strategy to formulate unique and differentiated products. Dr. Rubin and his team understand our vision of creating the best science-based health and wellness biocannabis products for consumers. Upon execution of these Agreements, Pivot will be well positioned to generate significant revenues in the State of Nevada, and with California coming online in Q4 2018, we now have access to two of the largest cannabis markets in the U.S.”

The U.S. is the epicenter of the legal cannabis market and it appears it will hold that position for the foreseeable future. In 2017 the worldwide legal marijuana trade grew by 37% and was worth $9.5 billion. At $8.5 billion, the U.S. accounted for 90% of it. At $0.6 billion Canada’s 2017 share was 6%. The rest of the world combined made up the remaining 4%.1Nevada’s Department of Taxation had projected that in the first year of legal recreational sales, dispensaries would sell $265 million worth of retail marijuana and generate roughly $50 million in tax revenue. However, through the first 10 months, Nevada dispensaries have sold north of $340 million and brought in $55 million in taxes.2 The total combined sales in Nevada for medical, recreational and marijuana-related goods since recreational became legal is $433.51 million.

About Healthcare Options for Patients Enterprises LLC (“HOPE”)

HOPE’s premium cannabis products are created by doctors and scientists specializing in pain management, orthopedic surgery, internal medicine, medical psychology, psychopharmacology, and biochemistry with the vision of helping people live better and healthier lives. For more information please visit www.hopemmj.com

About Pivot Pharmaceuticals Inc.

Pivot Pharmaceuticals Inc. is a biopharmaceutical company engaged in the development and commercialization of therapeutic pharmaceuticals and nutraceuticals using innovative drug delivery platform technologies. Pivot’s wholly-owned medical cannabis products division, Pivot Green Stream Health Solutions Inc. (“PGS” or “Pivot Green Stream”), conducts research, development and commercialization of cannabinoid-based nutraceuticals and pharmaceuticals. Pivot’s wholly-owned U.S. subsidiary, Pivot Naturals LLC, based in Costa Mesa, California, will manufacture and supply finished powderized cannabis products such as food additives, capsules, bulk powder and stick packs to the California market. PGS has acquired “RTIC” Ready-To-Infuse Cannabis oil-to-powder technology and Thrudermic Transdermal Nanotechnology (transdermal); acquired worldwide rights to BiPhasix™ Dermal Drug Delivery platform technology (topical), Solmic Solubilisation technology (oral), and Solumer™ Oral Drug Delivery technology; and an option to acquire worldwide rights to TriVair™ Nasal and Pulmonary Breath-Propelled Drug Delivery Systems™ for the delivery and commercialization of cannabinoid, cannabidiol (CBD), and tetrahydrocannabinol (THC)-based products. For more information please visit www.PivotPharma.com

Cautionary Statement

Except for historical information contained herein, the matters set forth above may be forward-looking statements that involve certain risks and uncertainties that could cause actual results to differ from those in the forward-looking statements. Words such as anticipate, believe, estimate, expect, intend, and similar expressions, as they relate to Pivot Pharmaceuticals Inc., Pivot Green Stream Health Solutions Inc., Pivot Naturals, LLC, Healthcare Options for Patients Enterprises LLC, HOPE Cannabis Products Ltd., or its management, identify forward-looking statements. Such forward-looking statements are based on the current beliefs of management, as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, such as the failure to meet the conditions imposed by the CSE or other securities regulators, the level of business and consumer spending, the amount of sales of Pivot’s products, statements with respect to internal expectations, the competitive environment within the industry, the ability of Pivot to continue to expand its operations, the level of costs incurred in connection with Pivot’s expansion efforts, economic conditions in the industry, and the financial strength of Pivot’s customers and suppliers. Pivot does not undertake any obligation to update such forward-looking statements. Investors are also directed to consider all other risks and uncertainties.

_________________________________
1 https://www.forbes.com/sites/thomaspellechia/2018/06/26/in-2017-beyond-u-s-enjoys-the-highest-legal-cannabis-market-share-worldwide/
2 https://www.reviewjournal.com/news/pot-news/nevadas-marijuana-industry-growth-big-surprise-in-first-legal-year/

Cision View original content:http://www.prnewswire.com/news-releases/pivot-monetizes-rtic-technology-and-enters-nevada-cannabis-market-with-strategic-partner-300693783.html

SOURCE Pivot Pharmaceuticals Inc.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading